Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD)

View source ↗

Summary

The update discusses approaches to defining endpoints for LGMD trials and the challenges involved. It highlights considerations for trial design and measurement…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Limb Girdle Muscular Dystrophy, Muscular Dystrophies | Status: COMPLETED